These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
7292 related items for PubMed ID: 2610585
21. Synthesis and hypoxia-selective cytotoxicity of a 2-nitroimidazole mustard. Lee HH, Palmer BD, Wilson WR, Denny WA. Bioorg Med Chem Lett; 1998 Jul 07; 8(13):1741-4. PubMed ID: 9873426 [Abstract] [Full Text] [Related]
22. Synthesis and bioevaluation of a series of alkyl ethers of p-N,N-bis(2-chloroethyl)aminophenol. Wise JW, Wynn JE, Beamer RL, Bauguess CT. J Pharm Sci; 1982 May 07; 71(5):561-5. PubMed ID: 7097504 [Abstract] [Full Text] [Related]
23. Reductive chemistry of the novel hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide. Palmer BD, van Zijl P, Denny WA, Wilson WR. J Med Chem; 1995 Mar 31; 38(7):1229-41. PubMed ID: 7707325 [Abstract] [Full Text] [Related]
24. [Effect of antineoplastic agents on tumor cells in vivo and in vitro (literature review)]. Merkulov MF, Shelaputina ZF, Leskova SG, Belinskiĭ VA, Talipov ASh. Farmakol Toksikol; 1971 Mar 31; 34(4):490-504. PubMed ID: 4334362 [No Abstract] [Full Text] [Related]
25. DNA-directed alkylating agents. 1. Structure-activity relationships for acridine-linked aniline mustards: consequences of varying the reactivity of the mustard. Gourdie TA, Valu KK, Gravatt GL, Boritzki TJ, Baguley BC, Wakelin LP, Wilson WR, Woodgate PD, Denny WA. J Med Chem; 1990 Apr 31; 33(4):1177-86. PubMed ID: 2319563 [Abstract] [Full Text] [Related]
27. Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide. Palmer BD, Wilson WR, Anderson RF, Boyd M, Denny WA. J Med Chem; 1996 Jun 21; 39(13):2518-28. PubMed ID: 8691449 [Abstract] [Full Text] [Related]
28. Antitumor effect of N alpha-benzyloxycarbonyl-N,N-bis-(2-halogenethyl)-hydrazide derivatives of amino acids. Karaivanova MH, Zakhariev SG, Golovinsky EV. Neoplasma; 1980 Jun 21; 27(2):137-42. PubMed ID: 7393353 [Abstract] [Full Text] [Related]
30. The primary in vitro antitumor screening of "half-mustard type" phenothiazines. Wuonola MA, Palfreyman MG, Motohashi N, Kawase M, Gabay S, Nacsa J, Molnár J. Anticancer Res; 1997 Jun 21; 17(5A):3409-23. PubMed ID: 9413180 [Abstract] [Full Text] [Related]
31. Plasmin-activated prodrugs for cancer chemotherapy. 1. Synthesis and biological activity of peptidylacivicin and peptidylphenylenediamine mustard. Chakravarty PK, Carl PL, Weber MJ, Katzenellenbogen JA. J Med Chem; 1983 May 21; 26(5):633-8. PubMed ID: 6221099 [Abstract] [Full Text] [Related]
32. Inhibition of human prostatic tumour acid phosphatase by N,N-p-di-2-chloroethylaminophenol, N,N-p-di-2-chloroethylaminophenyl phosphate and other difunctional nitrogen mustards. Workman P. Chem Biol Interact; 1978 Jan 21; 20(1):103-12. PubMed ID: 630640 [Abstract] [Full Text] [Related]
33. Aniline mustard analogues of the DNA-intercalating agent amsacrine: DNA interaction and biological activity. Fan JY, Valu KK, Woodgate PD, Baguley BC, Denny WA. Anticancer Drug Des; 1997 Apr 21; 12(3):181-203. PubMed ID: 9154110 [Abstract] [Full Text] [Related]
34. Correlation of resistance to nitrogen mustards in chronic lymphocytic leukemia with enhanced removal of melphalan-induced DNA cross-links. Torres-Garcia SJ, Cousineau L, Caplan S, Panasci L. Biochem Pharmacol; 1989 Sep 15; 38(18):3122-3. PubMed ID: 2783167 [No Abstract] [Full Text] [Related]
35. Derivatives of nitrogen mustard anticancer agents with improved cytotoxicity. Antoni F, Bernhardt G. Arch Pharm (Weinheim); 2021 Apr 15; 354(4):e2000366. PubMed ID: 33283341 [Abstract] [Full Text] [Related]
36. The mechanisms of action of antitumor compounds. Belousova AK. Natl Cancer Inst Monogr; 1977 Mar 15; (45):183-93. PubMed ID: 73135 [No Abstract] [Full Text] [Related]
37. Optimization of the N-lost drugs melphalan and bendamustine: synthesis and cytotoxicity of a new set of dendrimer-drug conjugates as tumor therapeutic agents. Scutaru AM, Wenzel M, Scheffler H, Wolber G, Gust R. Bioconjug Chem; 2010 Oct 20; 21(10):1728-43. PubMed ID: 20849062 [Abstract] [Full Text] [Related]
38. In vitro comparative studies of the myelotoxicity and antitumor activity of 6-[bis-(2-chloroethyl)-amino]-6-deoxy-D-glucose versus melphalan utilizing the CFU-C and HTSCA assays. Lazarus P, Dufour M, Isabel G, Panasci LC. Cancer Chemother Pharmacol; 1986 Oct 20; 16(2):148-52. PubMed ID: 3948300 [Abstract] [Full Text] [Related]
39. Synthesis and antitumor activity of new benzoheterocyclic derivatives of distamycin A. Baraldi PG, Romagnoli R, Beria I, Cozzi P, Geroni C, Mongelli N, Bianchi N, Mischiati C, Gambari R. J Med Chem; 2000 Jul 13; 43(14):2675-84. PubMed ID: 10893305 [Abstract] [Full Text] [Related]
40. Hypoxia-selective antitumor agents. 9. Structure-activity relationships for hypoxia-selective cytotoxicity among analogues of 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide. Palmer BD, Wilson WR, Atwell GJ, Schultz D, Xu XZ, Denny WA. J Med Chem; 1994 Jul 08; 37(14):2175-84. PubMed ID: 8035424 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]